Companies › ATAI

ATAIBECKLEY (ATAI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002081043 · EDGAR filings · Updated 2026-07-27

ATAIBECKLEY (ATAI) has reported institutional ownership of 27.0%, with 176 institutional managers holding positions valued at $348.8M per the latest 13F reporting period. SEC filings include an active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — SCHEDULE 13D/A filed
• 2026-07-16 — DEFA14A filed
• 2026-07-16 — DEFA14A filed
• 2026-07-16 — DEFA14A filed
• 2026-07-16 — DEFA14A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ATAIBECKLEY has 176 institutional holders and institutional ownership of 27.0%.

Insider activity

Insiders reported 4 transactions (0 buys, 2 sells) across 2 reporting insiders, with a net reported value of −$509.4K.

Data flags from SEC filings

Related companies

REGENXBIO INC (RGNX) · SUTRO BIOPHARMA INC (STRO) · FORTE BIOSCIENCES INC (FBRX) · NEUROPACE INC (NPCE) · ROCKET PHARMACEUTICALS I (RCKT) · BENITEC BIOPHARMA INC (BNTC)